Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE).
Arthritis Res Ther. 2021 Jan 6;23(1):9. doi: 10.1186/s13075-020-02387-6.
Arthritis Res Ther. 2021.
PMID: 33407801
Free PMC article.
Clinical Trial.
Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate.
Genovese MC, Smolen JS, Weinblatt ME, Burmester GR, Meerwein S, Camp HS, Wang L, Othman AA, Khan N, Pangan AL, Jungerwirth S.
Genovese MC, et al. Among authors: meerwein s.
Arthritis Rheumatol. 2016 Dec;68(12):2857-2866. doi: 10.1002/art.39808.
Arthritis Rheumatol. 2016.
PMID: 27390150
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial.
Genovese MC, Fleischmann R, Combe B, Hall S, Rubbert-Roth A, Zhang Y, Zhou Y, Mohamed MF, Meerwein S, Pangan AL.
Genovese MC, et al. Among authors: meerwein s.
Lancet. 2018 Jun 23;391(10139):2513-2524. doi: 10.1016/S0140-6736(18)31116-4. Epub 2018 Jun 18.
Lancet. 2018.
PMID: 29908670
Clinical Trial.
Item in Clipboard
Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs.
Strand V, Schiff M, Tundia N, Friedman A, Meerwein S, Pangan A, Ganguli A, Fuldeore M, Song Y, Pope J.
Strand V, et al. Among authors: meerwein s.
Arthritis Res Ther. 2019 Dec 2;21(1):263. doi: 10.1186/s13075-019-2059-8.
Arthritis Res Ther. 2019.
PMID: 31791386
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study.
Kameda H, Takeuchi T, Yamaoka K, Oribe M, Kawano M, Zhou Y, Othman AA, Pangan AL, Kitamura S, Meerwein S, Tanaka Y.
Kameda H, et al. Among authors: meerwein s.
Rheumatology (Oxford). 2020 Nov 1;59(11):3303-3313. doi: 10.1093/rheumatology/keaa084.
Rheumatology (Oxford). 2020.
PMID: 32277824
Free PMC article.
Clinical Trial.
Item in Clipboard
Upadacitinib in patients from China, Brazil, and South Korea with rheumatoid arthritis and an inadequate response to conventional therapy.
Zeng X, Zhao D, Radominski SC, Keiserman M, Lee CK, Meerwein S, Enejosa J, Sui Y, Mohamed MF, Park W.
Zeng X, et al. Among authors: meerwein s.
Int J Rheum Dis. 2021 Dec;24(12):1530-1539. doi: 10.1111/1756-185X.14235. Epub 2021 Nov 15.
Int J Rheum Dis. 2021.
PMID: 34779576
Free PMC article.
Clinical Trial.
Item in Clipboard
Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate.
Emery P, Smolen JS, Ganguli A, Meerwein S, Bao Y, Kupper H, Chen N, Kavanaugh A.
Emery P, et al. Among authors: meerwein s.
Rheumatology (Oxford). 2016 Aug;55(8):1458-65. doi: 10.1093/rheumatology/kew056. Epub 2016 Apr 25.
Rheumatology (Oxford). 2016.
PMID: 27114561
Clinical Trial.
Item in Clipboard
Cite
Cite